<?xml version="1.0" encoding="UTF-8"?>
<rss xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:taxo="http://purl.org/rss/1.0/modules/taxonomy/" version="2.0">
  <channel>
    <title>NewsTin - Oncology</title>
    <link>http://www.newstin.com/us/ONCOLOGY</link>
    <description>Global Social News Platform</description>
    <copyright>Copyright © 2006 I2S a.s.</copyright>
    <dc:rights>Copyright © 2006 I2S a.s.</dc:rights>
    <item>
      <title>Oncology Market to Grow to $85 Billion by 2013, According to New Therapeutic Study by Cutting...</title>
      <link>http://www.newstin.com/tag/us/66276326</link>
      <description>RESEARCH TRIANGLE PARK, NC--(Marketwire - July 3, 2008) - The oncology market will grow from $57 billion in 2007 to more than $85 billion in 2013, according to a new report by Cutting Edge Information. Along the way, many drugs...</description>
      <pubDate>Thu, 03 Jul 2008 13:39:00 GMT</pubDate>
      <guid>http://www.newstin.com/tag/us/66276326</guid>
      <dc:date>2008-07-03T13:39:00Z</dc:date>
    </item>
    <item>
      <title>Oncology association ‘horrified’ by Specter’s vote against Medicare bill.</title>
      <link>http://www.newstin.com/tag/us/66284582</link>
      <description>Earlier this week, Politico reported that Sen. Arlen Specter (R-PA) switched his vote and opposed an increase in Medicare payments to doctors, after he made a deal with the White House. Officials promised Specter, who has been...</description>
      <pubDate>Thu, 03 Jul 2008 14:20:26 GMT</pubDate>
      <guid>http://www.newstin.com/tag/us/66284582</guid>
      <dc:date>2008-07-03T14:20:26Z</dc:date>
    </item>
    <item>
      <title>Maintenance Rituxan® Is Safe for Follicular Lymphoma</title>
      <link>http://www.newstin.com/tag/us/66334600</link>
      <description>Continued treatment for up to two years with Rituxan® (rituximab) is a safe therapeutic approach for the treatment of follicular lymphoma. These results were recently presented at the 2008 annual meeting of the American Society...</description>
      <pubDate>Thu, 03 Jul 2008 13:18:27 GMT</pubDate>
      <guid>http://www.newstin.com/tag/us/66334600</guid>
      <dc:date>2008-07-03T13:18:27Z</dc:date>
    </item>
    <item>
      <title>First CyberKnife System To Be Installed In Canada</title>
      <link>http://www.newstin.com/tag/us/66294606</link>
      <description>Accuray Incorporated, a global leader in the field of radiosurgery recently announced that Centre Hospitalier de l'Universite de Montreal (CHUM) has purchased a CyberKnife Robotic Radiosurgery System for installation at Hopital...</description>
      <pubDate>Thu, 03 Jul 2008 15:27:29 GMT</pubDate>
      <guid>http://www.newstin.com/tag/us/66294606</guid>
      <dc:date>2008-07-03T15:27:29Z</dc:date>
    </item>
    <item>
      <title>Emory Researcher Earns $600,000 Grant for Brain Tumor Research</title>
      <link>http://www.newstin.com/tag/us/66292000</link>
      <description>Erwin Van Meir, PhD, professor of neurosurgery and hematology and medical oncology, Emory University Winship Cancer Institute, has earned a three-year, $600,000 research grant from the Goldhirsh Found... [WebWire - Thursday,...</description>
      <pubDate>Thu, 03 Jul 2008 15:14:24 GMT</pubDate>
      <guid>http://www.newstin.com/tag/us/66292000</guid>
      <dc:date>2008-07-03T15:14:24Z</dc:date>
    </item>
    <item>
      <title>Company and People Notes: Schering-Plough and Merck Withdraw NDA and Terminate Respiratory Joint...</title>
      <link>http://www.newstin.com/tag/us/66277710</link>
      <description>Company Notes West Lafayette, IN (June 30)—Bioanalytical Systems (BASi) sold its Baltimore Clinical Pharmacology Research Unit to a subsidiary of Algorithme Pharma Holdings for a cash payment of $850,000. On June 24, BASi...</description>
      <pubDate>Thu, 03 Jul 2008 13:49:00 GMT</pubDate>
      <guid>http://www.newstin.com/tag/us/66277710</guid>
      <dc:date>2008-07-03T13:49:00Z</dc:date>
    </item>
    <item>
      <title>Nabriva Therapeutics Announces Appointment of New CEO</title>
      <link>http://www.newstin.com/tag/us/66195443</link>
      <description>Attention News Editors VIENNA, Austria, July 3 /CNW/ - Nabriva Therapeutics, a specialist in antibiotics development, announces that Dr. George Golumbeski has been appointed as Chief Executive Officer of the Company. Dr....</description>
      <pubDate>Thu, 03 Jul 2008 02:05:45 GMT</pubDate>
      <guid>http://www.newstin.com/tag/us/66195443</guid>
      <dc:date>2008-07-03T02:05:45Z</dc:date>
    </item>
    <item>
      <title>Texas Oncology Urges Texans To 'Save Your Skin:' Outsmart The Sun And Prevent Skin Cancer</title>
      <link>http://www.newstin.com/tag/us/66236723</link>
      <description>Now that school is out and the first day of summer is upon us, the cancer care experts at Texas Oncology remind Texans to "save your skin" by outsmarting the sun when spending time outdoors. Although the most prevalent cancer...</description>
      <pubDate>Thu, 03 Jul 2008 10:38:14 GMT</pubDate>
      <guid>http://www.newstin.com/tag/us/66236723</guid>
      <dc:date>2008-07-03T10:38:14Z</dc:date>
    </item>
    <item>
      <title>Linking Second-hand Smoke And Lung Cancer</title>
      <link>http://www.newstin.com/tag/us/66208525</link>
      <description>Editor's Choice Main Category: It is a widely accepted notion that second-hand smoke (SHS) is linked to lung cancer. In an article published in The Lancet Oncology, Dr Ahmad Besaratinia and Dr Gerd Pfeifer, Beckman (Research...</description>
      <pubDate>Thu, 03 Jul 2008 08:15:11 GMT</pubDate>
      <guid>http://www.newstin.com/tag/us/66208525</guid>
      <dc:date>2008-07-03T08:15:11Z</dc:date>
    </item>
    <item>
      <title>Targeted Therapies To Lead New Wave Of Breast Cancer Treatments</title>
      <link>http://www.newstin.com/tag/us/66258217</link>
      <description>Rising public awareness about breast cancer and the treatments available has greatly improved revenues in the overall breast cancer therapeutics market. To thrive in this highly competitive market, drug developers must offer...</description>
      <pubDate>Thu, 03 Jul 2008 12:23:08 GMT</pubDate>
      <guid>http://www.newstin.com/tag/us/66258217</guid>
      <dc:date>2008-07-03T12:23:08Z</dc:date>
    </item>
  </channel>
</rss>

